Clinical Trials in Houston

Showing 12121-12140 of 15,366 trials

HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

NCT01913106

The purpose of this study is to conduct a Phase I - II clinical trial to extend preclinical studies involving in situ HSV-tk + Valacyclovir gene therapy in combination with brachytherapy for recurrent prostate cancer. This will provide a novel therapeutic approach to prostate cancer and hopefully impact on the development of metastatic disease and the control of preexisting metastasis.

Prostatic Neoplasms

The Methodist Hospital Research Institute25 participantsStarted Jun 2007

Houston, Texas, United States

TERMINATEDPhase 3< 1 mile

A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC

NCT01798485

The purpose of this study is to determine whether combining ganetespib (STA-9090) with docetaxel is more effective than docetaxel alone in the treatment of patients with advanced non-small cell lung cancer.

Non-Small-Cell Lung AdenocarcinomaNon-small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IV+1 more

Synta Pharmaceuticals Corp.696 participantsStarted Apr 2013

Flagstaff, Arizona, United States • Prescott Valley, Arizona, United States • Sedona, Arizona, United States +264 more locations

HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC

Find Trials by Condition in Houston

Expanded Access Program for Maraviroc At Multiple Centers

Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)

Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder

6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA

Study of 18F-Fluoro-PEG6-IPQA

Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus

Peak Study - A Study of Pegasys (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC).

A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients

A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer

Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma

Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke

Trial of Caldolor for Treatment of Pain in Post-Operative Adult Patients

Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery

A Study of Two Fabrazyme (Agalsidase Beta) Dosing Regimens in Treatment-naïve, Male Pediatric Patients Without Severe Symptoms

A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies

A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia

A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1